Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Qdenga, dengue tetravalent vaccine (live, attenuated), Date of authorisation: 05/12/2022, Revision: 1, Status: Authorised
TO: